Amoxirut-250 DT Tablet

Amoxicillin 250 mg Dispersible Tablets — Broad-Spectrum Penicillin Antibiotic

Amoxirut-250 DT Tablet — Amoxicillin 250 mg (Dispersible) from Trumac Healthcare PCD Pharma Franchise India

Composition Amoxicillin 250 mg (Dispersible)
Dosage Form Dispersible Tablet
Pack Type Strip
Pack Size 10 x 10 Dispersible Tablets
MRP ₹ 495
Therapy G.P. + Orthopaedics + Gynaecology + Dental + ENT — Aminopenicillin Antibiotic (Beta-lactam)
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Amoxirut-250 DT Tablet

Amoxirut-250 DT Tablet contains Amoxicillin 250 mg in a dispersible (DT) format that dissolves rapidly in water to form a palatable suspension. This makes Amoxirut-250 DT especially suited to paediatric use and to adult patients who cannot swallow conventional tablets.

Amoxicillin is a broad-spectrum aminopenicillin with proven efficacy against a wide range of community-acquired bacterial infections — respiratory tract, ENT, dental, urinary tract, skin and soft tissue, and Helicobacter pylori eradication (as part of combination therapy). It is one of the most widely prescribed antibiotics in primary care.

Amoxirut-250 DT is manufactured by Trumac Healthcare under WHO-GMP conditions and is one of the company’s high-volume antibiotic SKUs. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Otitis media in children
  • Acute and chronic bronchitis, community-acquired pneumonia
  • Acute sinusitis and pharyngitis
  • Uncomplicated urinary tract infections
  • Dental abscess and odontogenic infections
  • Helicobacter pylori eradication (combination therapy)
  • Skin and soft tissue infections

Mechanism of Action

Amoxicillin is a beta-lactam antibiotic that binds penicillin-binding proteins (PBPs) on bacterial cell walls. This inhibits the final transpeptidation step of peptidoglycan synthesis, weakening the cell wall and causing osmotic lysis of dividing bacteria. The aminopenicillin side-chain extends activity to many gram-negative organisms beyond classical penicillin spectrum.

Dosage & Administration

Children: 20–40 mg/kg/day in 3 divided doses, dispersed in water. Adults: 250–500 mg three times daily (every 8 hours). Course duration typically 5–7 days; longer for severe infections. Take with or without food.

Side Effects

Diarrhoea, nausea, vomiting, mild skin rash. Less commonly: pseudomembranous colitis with prolonged use, allergic skin reactions (urticaria, rash). Rare: anaphylaxis, hepatitis, Stevens-Johnson syndrome, interstitial nephritis.

Contraindications & Precautions

Hypersensitivity to penicillins, cephalosporins or any beta-lactam antibiotic. History of severe allergic reaction to amoxicillin. Infectious mononucleosis (high rate of rash). Caution in renal impairment.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Amoxirut-250 DT Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Amoxirut-250 DT Tablet used for?

Amoxirut-250 DT is a dispersible tablet of Amoxicillin 250 mg used to treat common bacterial infections in children and adults — respiratory tract, ENT, dental, urinary tract and skin infections.

How is a dispersible tablet taken?

Place the tablet in a small amount of water (about 10 ml) and stir until dispersed; drink the entire suspension immediately. Particularly suitable for children and adults with swallowing difficulty.

Is Amoxirut-250 DT available for PCD pharma franchise?

Yes, Trumac Healthcare offers Amoxirut-250 DT on monopoly-based PCD pharma franchise and for third-party manufacturing — a high-volume paediatric/general SKU.

How should Amoxirut-250 DT be stored?

Store below 30 °C in a dry place, away from direct sunlight and moisture.

Is Amoxirut-250 DT WHO-GMP certified?

Yes, Amoxirut-250 DT Tablet is manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.